To further examine the clinical implication of METTL4 and 6mA, we measured the 6mA levels in upper tract urothelial cancer (UTUC) patient samples since HIF-1α contributes to tumor progression in UTUC patients [40]. This evidence concerns the gene HIF1A and renal pelvis/ureter urothelial carcinoma.